RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Carl Zeiss Meditec Equity 2024

Carl Zeiss Meditec Equity

2.16 B EUR

Carl Zeiss Meditec Dividend yield

1.19 %

Ticker

AFX.DE

ISIN

DE0005313704

WKN

531370

In 2024, Carl Zeiss Meditec's equity was 2.16 B EUR, a 7.16% increase from the 2.02 B EUR equity in the previous year.

Carl Zeiss Meditec Aktienanalyse

What does Carl Zeiss Meditec do?

Carl Zeiss Meditec AG is a globally leading provider of medical technologies and devices for diagnostics and therapy. The company's history dates back to the founding of Carl Zeiss in 1846 in Jena, Germany. It has a long tradition in the development and manufacture of optical devices, particularly microscopes and binoculars. In 1996, Carl Zeiss decided to spin off its medical technology business segment and establish Carl Zeiss Meditec AG. Since then, the company has developed a wide portfolio of products used in ophthalmology and other medical fields. The business model of Carl Zeiss Meditec is based on three pillars: devices for diagnostics and therapy, software, and services. The devices are offered in various divisions specialized in specific application areas. The ophthalmology division is the largest and most well-known area of the company. It offers a wide range of diagnostic and therapy devices used in the treatment of eye diseases such as glaucoma, cataract, and retinal disorders. The products of the ophthalmology division include OCT systems (optical coherence tomography) for detailed examination of the retina, as well as VisuMax laser technology for correction of vision defects. Another important area of Carl Zeiss Meditec is the neurosurgery division. It offers devices for stereotactic neurosurgery used in the treatment of brain tumors, movement disorders, and other neurological conditions. The products of this division include the Kinevo stereotactic navigation system and the OPMI Neuro/NC4 surgical microscope series. In the dental division, Carl Zeiss Meditec provides innovative solutions for dentistry. This includes optical impression systems (Artemis), CAD/CAM systems, and dental microscopes. In addition to products, Carl Zeiss Meditec also offers software solutions for medical imaging and data processing. The FORUM software platform allows for intuitive management of medical images and findings. The company also provides training and education for doctors and medical professionals. The products of Carl Zeiss Meditec are known for their high quality, reliability, and precision. The company focuses on innovative technologies and continuously invests in research and development to strengthen its position as a market leader in the medical technology industry. Carl Zeiss Meditec is present in more than 60 countries worldwide and employs around 3,000 people. It is headquartered in Jena, Germany, and has additional locations in the United States, Canada, China, India, and other countries. Overall, Carl Zeiss Meditec AG is an innovative and reliable partner for the medical technology industry. Its wide range of products and services contributes to improving the health of millions of people worldwide. Carl Zeiss Meditec ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Carl Zeiss Meditec's Equity

Carl Zeiss Meditec's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Carl Zeiss Meditec's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Carl Zeiss Meditec's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Carl Zeiss Meditec's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Carl Zeiss Meditec’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Carl Zeiss Meditec Stock

What is the equity of Carl Zeiss Meditec this year?

Carl Zeiss Meditec has equity of 2.16 B EUR this year.

What was the equity of Carl Zeiss Meditec compared to the previous year?

The equity of Carl Zeiss Meditec has increased/decreased by 7.16% increased compared to the previous year.

What impact does a high equity have on investors of Carl Zeiss Meditec?

A high equity is advantageous for investors of Carl Zeiss Meditec as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Carl Zeiss Meditec?

A low equity can be a risk for investors of Carl Zeiss Meditec, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Carl Zeiss Meditec affect the company?

An increase in equity of Carl Zeiss Meditec can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Carl Zeiss Meditec affect the company?

A reduction in equity of Carl Zeiss Meditec can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Carl Zeiss Meditec?

Some factors that can affect the equity of Carl Zeiss Meditec include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Carl Zeiss Meditec so important for investors?

The equity of Carl Zeiss Meditec is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Carl Zeiss Meditec take to change the equity?

To change equity, Carl Zeiss Meditec can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Carl Zeiss Meditec pay?

Over the past 12 months, Carl Zeiss Meditec paid a dividend of 1.1 EUR . This corresponds to a dividend yield of about 1.19 %. For the coming 12 months, Carl Zeiss Meditec is expected to pay a dividend of 1.22 EUR.

What is the dividend yield of Carl Zeiss Meditec?

The current dividend yield of Carl Zeiss Meditec is 1.19 %.

When does Carl Zeiss Meditec pay dividends?

Carl Zeiss Meditec pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Carl Zeiss Meditec?

Carl Zeiss Meditec paid dividends every year for the past 20 years.

What is the dividend of Carl Zeiss Meditec?

For the upcoming 12 months, dividends amounting to 1.22 EUR are expected. This corresponds to a dividend yield of 1.32 %.

In which sector is Carl Zeiss Meditec located?

Carl Zeiss Meditec is assigned to the 'Health' sector.

Wann musste ich die Aktien von Carl Zeiss Meditec kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Carl Zeiss Meditec from 3/26/2024 amounting to 1.1 EUR, you needed to have the stock in your portfolio before the ex-date on 3/22/2024.

When did Carl Zeiss Meditec pay the last dividend?

The last dividend was paid out on 3/26/2024.

What was the dividend of Carl Zeiss Meditec in the year 2023?

In the year 2023, Carl Zeiss Meditec distributed 0.9 EUR as dividends.

In which currency does Carl Zeiss Meditec pay out the dividend?

The dividends of Carl Zeiss Meditec are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Carl Zeiss Meditec stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank

Andere Kennzahlen von Carl Zeiss Meditec

Our stock analysis for Carl Zeiss Meditec Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Carl Zeiss Meditec Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.